1-benzyl-4-chloro-5-hydroxy-5-phenyl-1H-pyrrol-2(5H)-one

ID: ALA3818410

Chembl Id: CHEMBL3818410

PubChem CID: 89913684

Max Phase: Preclinical

Molecular Formula: C17H14ClNO2

Molecular Weight: 299.76

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1C=C(Cl)C(O)(c2ccccc2)N1Cc1ccccc1

Standard InChI:  InChI=1S/C17H14ClNO2/c18-15-11-16(20)19(12-13-7-3-1-4-8-13)17(15,21)14-9-5-2-6-10-14/h1-11,21H,12H2

Standard InChI Key:  PSAAJCUJOJAQJZ-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

AGS (1999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cckar Cholecystokinin A receptor (1695 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAC13 (45 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAC16 (28 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 299.76Molecular Weight (Monoisotopic): 299.0713AlogP: 3.00#Rotatable Bonds: 3
Polar Surface Area: 40.54Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.11CX Basic pKa: CX LogP: 3.35CX LogD: 3.35
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.95Np Likeness Score: -0.08

References

1. Lattmann E, Russell ST, Schwalbe CH, Shortt A, Balaram PN, Theochari E, Alharbi M, Narayanan R, Lattmann P.  (2016)  Cholecystokinin-1 receptor antagonists: 5-hydroxy-5-aryl-pyrrol-2-ones as anticancer agents,  (6): [10.1039/C6MD00052E]

Source